CONSULTANT CONNECTION – TAKE IT TO THE CLINIC |
Help your biotech clients save time and money on Phase I trials while maintaining cGMP quality. Learn more in this issue of Consultant Connection. |
Quality, Speed and Cost Savings for Your Phase I Drug Manufacture |
What if you could bring your clients a fast and safe solution for cGMP manufacture of their Phase I drugs right at the clinical research unit (CRU) – instead of engaging a contract manufacturing organization (CMO)? This solution simplifies the drug development journey for small biopharma organizations looking to streamline and also offers:
|
Manufacturing is estimated to be 20-40% of the entire cost of developing of a drug. cGMP at a CMO results in 200-300% excess API, whereas cGMP at a CRU results in only 1-25% excess API. |
Contact Your Consultant Connectors Lecia Johnson and her team are standing by to provide you with seamless access to Covance global solutions for consultants – nonclinical and clinical, registration and market access. Contact us today – we look forward to helping you succeed. Contact the team > |
PHASE I DRUG MANUFACTURE FOR QUALITY, SPEED AND COST SAVINGS Ask your representative for a client study on this industry-leading topic. |
cGMP Resources |
Past Consultant Connection Articles Explore more ways to advance your client's programs: |